Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Meiser

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Transplantation Proceedings|December 1, 1994
New trends in clinical immunosuppressionB M Meiser, B Reichart
Transplantation|March 1, 1991
The importance of the spleen for the immunosuppressive action of cyclosporine in transplantationB M Meiser, R E Morris
Lancet (London, England)|November 23, 1991
Effects of cyclosporin, FK506, and rapamycin on graft-vessel diseaseB M Meiser, M E Billingham, R E Morris
The Heart Surgery Forum|January 23, 2003
Cell transplantation--a potential therapy for cardiac repair in the future?Helmut Gulbins, B M Meiser, H Reichenspurner, et al.
Cardiologia (Rome, Italy)|November 11, 1998
The continuing challenge of cardiac transplant arteriosclerosisM Weis, B M Meiser, B Reichart, et al.
Journal of the American College of Cardiology|August 31, 2001
Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantationM Weis, S Pehlivanli, B M Meiser, et al.
Transplantation Proceedings|February 1, 1991
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactionsR E Morris, B M Meiser, J Wu, et al.
Transplantation Proceedings|December 1, 1992
Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresisK Wenke, J Thiery, N Arndtz, et al.
Kidney International. Supplement|December 1, 1995
What is the role of lipid lowering therapy in heart-allograft failure?B Reichart, B M Meiser, K Wenke, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1994
One heart transplanted successfully twiceB M Meiser, P Uberfuhr, H Reichenspurner, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Transplantation Proceedings|December 1, 1994
New trends in clinical immunosuppressionB M Meiser, B Reichart
Transplantation|March 1, 1991
The importance of the spleen for the immunosuppressive action of cyclosporine in transplantationB M Meiser, R E Morris
Lancet (London, England)|November 23, 1991
Effects of cyclosporin, FK506, and rapamycin on graft-vessel diseaseB M Meiser, M E Billingham, R E Morris
The Heart Surgery Forum|January 23, 2003
Cell transplantation--a potential therapy for cardiac repair in the future?Helmut Gulbins, B M Meiser, H Reichenspurner, et al.
Cardiologia (Rome, Italy)|November 11, 1998
The continuing challenge of cardiac transplant arteriosclerosisM Weis, B M Meiser, B Reichart, et al.
Journal of the American College of Cardiology|August 31, 2001
Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantationM Weis, S Pehlivanli, B M Meiser, et al.
Transplantation Proceedings|February 1, 1991
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactionsR E Morris, B M Meiser, J Wu, et al.
Transplantation Proceedings|December 1, 1992
Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresisK Wenke, J Thiery, N Arndtz, et al.
Kidney International. Supplement|December 1, 1995
What is the role of lipid lowering therapy in heart-allograft failure?B Reichart, B M Meiser, K Wenke, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1994
One heart transplanted successfully twiceB M Meiser, P Uberfuhr, H Reichenspurner, et al.
Pageof 5